271 related articles for article (PubMed ID: 19275545)
1. Relationship between the pharmacokinetics of levosimendan and its effects on cardiovascular system.
Antoniades C; Antonopoulos AS; Tousoulis D; Bakogiannis C; Stefanadi E; Stefanadis C
Curr Drug Metab; 2009 Feb; 10(2):95-103. PubMed ID: 19275545
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan: beyond its simple inotropic effect in heart failure.
Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
[TBL] [Abstract][Full Text] [Related]
3. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
Cavusoglu Y
Expert Opin Pharmacother; 2007 Apr; 8(5):665-77. PubMed ID: 17376021
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
Kivikko M; Lehtonen L
Curr Pharm Des; 2005; 11(4):435-55. PubMed ID: 15725064
[TBL] [Abstract][Full Text] [Related]
5. A promising new inotrope: levosimendan.
Fotbolcu H; Duman D
Anadolu Kardiyol Derg; 2010 Apr; 10(2):176-82. PubMed ID: 20382619
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure.
Kivikko M; Antila S; Eha J; Lehtonen L; Pentikäinen PJ
J Clin Pharmacol; 2002 Jan; 42(1):43-51. PubMed ID: 11808823
[TBL] [Abstract][Full Text] [Related]
7. Novel biologic mechanisms of levosimendan and its effect on the failing heart.
Parissis JT; Andreadou I; Bistola V; Paraskevaidis I; Filippatos G; Kremastinos DT
Expert Opin Investig Drugs; 2008 Aug; 17(8):1143-50. PubMed ID: 18616411
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects.
Pathak A; Lebrin M; Vaccaro A; Senard JM; Despas F
J Clin Pharm Ther; 2013 Oct; 38(5):341-9. PubMed ID: 23594161
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan, a new calcium-sensitizing inotrope for heart failure.
Ng TM
Pharmacotherapy; 2004 Oct; 24(10):1366-84. PubMed ID: 15628834
[TBL] [Abstract][Full Text] [Related]
10. Levosimendan, a new inotropic and vasodilator agent.
Toller WG; Stranz C
Anesthesiology; 2006 Mar; 104(3):556-69. PubMed ID: 16508404
[TBL] [Abstract][Full Text] [Related]
11. Levosimendan.
Figgitt DP; Gillies PS; Goa KL
Drugs; 2001; 61(5):613-27; discussion 628-9. PubMed ID: 11368286
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan: from basic science to clinical practice.
Parissis JT; Rafouli-Stergiou P; Paraskevaidis I; Mebazaa A
Heart Fail Rev; 2009 Dec; 14(4):265-75. PubMed ID: 19101796
[TBL] [Abstract][Full Text] [Related]
13. The hemodynamic and pharmacokinetic interactions between chronic use of oral levosimendan and digoxin in patients with NYHA Classes II-III heart failure.
Harjola VP; Oikarinen L; Toivonen L; Jurkko R; Puttonen J; Sarapohja T; Sundberg S; Nieminen MS
Int J Clin Pharmacol Ther; 2008 Aug; 46(8):389-99. PubMed ID: 18793580
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan: a novel agent in heart failure.
Koumallos N; Antoniades C; Tousoulis D; Shirodaria C; Stefanadis C
Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):185-91. PubMed ID: 18221085
[TBL] [Abstract][Full Text] [Related]
15. Levosimendan: a unique approach to the treatment of heart failure.
Nawarskas JJ; Anderson JR
Heart Dis; 2002; 4(4):265-71. PubMed ID: 12147186
[TBL] [Abstract][Full Text] [Related]
16. Levosimendan: a new option in acute cardiac failure.
Holley AD; Ziegenfuss M
Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641
[No Abstract] [Full Text] [Related]
17. Levosimendan: a review of its use in the management of acute decompensated heart failure.
Innes CA; Wagstaff AJ
Drugs; 2003; 63(23):2651-71. PubMed ID: 14636085
[TBL] [Abstract][Full Text] [Related]
18. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
Earl GL; Fitzpatrick JT
Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of simendan, a novel calcium sensitizer, in healthy volunteers.
Lilleberg J; Antila S; Karlsson M; Nieminen MS; Pentkäinen PJ
Clin Pharmacol Ther; 1994 Nov; 56(5):554-63. PubMed ID: 7955820
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan: dual mechanisms for acute heart failure...and beyond?
Ng TM; Akhter MW
Minerva Cardioangiol; 2005 Dec; 53(6):565-84. PubMed ID: 16333239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]